Replies to post #126818 on Biotech Values

[Regulardoc]

What is this??? Did Amphastar and WPI only get approval for these dosages? If so, this will have minimal effect on outpatient usage and only slightly greater effect on inpatient usage!! Did they not receive FDA approval for the 3omg, 40mg or 80mg prefilled syringe dosages?

Also, if Amphastar is marketing it to non-retail channels, I would rather compete with Amphastar rather than Watson.

Anybody know what strengths actually received approval?

If they did not receive approval for prefilled syringes at the 30, 40, 60, 80mg dosages, this would not have much effect on MNTA, unless the NVS revenue agreement is not dosage form related.